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Among the many aspects that contribute to the wellness of each individual, healthy
and younger-looking skin play a relevant role, as clearly shown by the important
growth of the skin-care products market observed in recent years. In this scenario,
the field of cosmeceuticals appears particularly promising, being based on cosmetic
products containing active ingredients. Among these, several peptides were proposed for
cosmeceutical applications, thanks to their specific interaction with biological targets. In
this mini-review, we report some of the most investigated and used peptides for cosmetic
formulations, taking into account that cosmeceutical peptides are basically divided into
three main categories (i.e., neurotransmitter inhibitors, carriers, and signal peptides).
Special attention was payed to the scientific studies supporting the claimed biological
activity of these peptides, as a fundamental aspect that should underpin the growth of
this field in the framework of a sustainable wellness economy.
Keywords: signal peptides, neurotransmitter peptide inhibitors, carrier peptides, sustainable wellness economy,
peptide-based cosmetics
INTRODUCTION
In 2015 the United Nation defined 17 Sustainable Development Goals (SDG) that can contribute
to change the world for the better. The third of these goals is to establish “good health and well-
being”, thus indicating that health and wellness are strictly linked. Among the many aspects that
contribute to the wellness of each individual, healthy and younger-looking skin play a relevant role,
as clearly shown by the important growth of the skin-care products market observed in recent years
(Global Wellness Institute, 2018). This is a wide market segment, ranging from pure cosmetics to
dermatological products and including the so-called cosmeceutical products, which lie in a gray
area between cosmetics and drugs and, despite their large use, to date are not recognized from the
Food and Drug Administration.
Peptides entered the cosmeceutical field in 1973 when Pickart proposed the synthetic peptide
GHK as a signal peptide enhancing collagen production and acting as a carrier peptide when
complexed with Cu(II) (Pickart and Thaler, 1973). Since then, thanks to their versatility, a plethora
of peptides of cosmeceutical interest have been developed in response to the most frequent and not
fully satisfied market requests.
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Perception of beauty is tied to the idea of youth. This is why
a large number of peptides proposed in the field of cosmetics
are used as anti-aging products. In this field several products
to adorn skin have grown in popularity and they are sought
after by women but also men. External agents, such as smog,
together with endogenous pathways, such as oxidative stress,
affect skin cell oxidative damages, resulting in skin aging. To
adjust the skin biological clock, it is necessary to get and
maintain a good balance between structural protein synthesis and
degradation. In fact, most of the products on the market act via
this mechanism, regulating collagen turnover. A second possible
pathway is to obtain a temporary improvement of skin firmness
by blocking or promoting some neurotransmitters, thus leading
to a decrease of fine and age-induced wrinkles. Care should
be taken to the association between good topical care products
and food supplements in which the term “peptide” is starting to
be (ab)used to identify mostly not well identified hydrolysates.
Nevertheless, women today understood the importance of
reading product labels and INCI (International Nomenclature
of Cosmetic Ingredients) lists. In fact, more and more women
ask for specific information regarding the active principles
used in cosmeceuticals and they are attracted by scientific data
demonstrating the number of claims reported by the cosmetic
industry. It has to be clearly emphasized that cosmeceuticals,
differently from cosmetics, contain active ingredients whose
activity claim should be supported by scientific investigations.
Only at these conditions the use of active ingredients in cosmetic
formula is acceptable (Papini, 2010).
In this mini-review we will list some of the newest synthetic
peptide-based cosmeceuticals discovered in the last decade,
classified as neurotransmitter inhibitor peptides, carrier peptides
and signal peptides. Figure 1 also reports their bioactivity and
when available, original synthetic strategy.
NEUROTRANSMITTER INHIBITOR
PEPTIDES
Fine lines and wrinkles are getting formed, among other,
due to the muscle cramps. These movements, provoked both
involuntary and knowingly, are strictly connected with large
number of SNARE (Soluble N-ethylmaleimide-sensitive factor
Activating protein REceptor) complexes. Acetylcholine (ACh), the
main neurotransmitter involved in this process, is released from
vesicles as the result of a reaction cascade mediated by SNAP
(SyNaptosome-Associated Protein) receptor protein. It controls
directly the synaptic vesicle fusion for ACh release, involving
SNARE complex formation (Lima and Pedriali Moraes, 2018).
Once ACh is released, it binds to the appropriate receptor and
triggers muscle cramps. Some peptides with similar sequence
to the synaptic proteins can potentially inhibit this reaction.
Therefore, those are termed neurotransmitter inhibitor peptides
(Schagen, 2017).
SNAP-25 (SyNaptosome-Associated Protein, molecular weight
25 kDa), which is essential for ACh release from vesicles with
the presynaptic vesicle, is particularly targeted by the well-known
botulinum neurotoxin type A. Botulinum neurotoxin type B has a
different mechanism of action. In fact, it leads to VAMP (Vesicle-
Associated Membrane Protein) cleavage, necessary for the release
of ACh (Lupo and Cole, 2007). Botulinum toxins are widely
applied as a reference while neurotransmitter inhibitor peptides
are tested as cosmeceuticals.
Acetyl Hexapeptide-3 (Argireline)
One of the best known peptide with neurotransmitter-
inhibiting properties is a synthetic hexapeptide, so-called acetyl
hexapeptide-3 and coined Argireline. The sequence Ac-Glu-
Glu-Met-Gln-Arg-Arg-NH2 (Blanes-Mira et al., 2002), covers
the N-terminal fragment domain of SNAP-25, promoting the
inhibition of Ca2+-dependent catecholamine release through the
interrupted formation of SNARE complex. In comparison to
the botulinum toxin, Argireline presents similar potency but
lower efficacy. However, it can be considered as a safe, non-toxic
alternative for botulinum family compounds.
Recent data on acetyl hexapeptide-3, reported in the literature,
comprise its skin permeability, also with the use of microneedles
(Krishnan et al., 2014; Zhang et al., 2014). Skin permeation
depends on various factors (e.g., pH, charge, molecular
weight, concentration, and background electrolytes). These
characteristics will have always to be taken into consideration
during peptide delivery optimization. Microneedles enhance
this process even 40-fold compared to passive diffusion. The
clinical studies with Argireline peptide confirmed its efficiency
and its potential as an active ingredient to be used in
cosmeceuticals (Tadini et al., 2015; Raikou et al., 2017). Very
recently, Lim et al. reported a relevant, wide study on acetyl
hexapeptide-3, designing eye patches with microneedles to
increase peptide delivery (Lim et al., 2020). Skin permeation was
successfully improved also by nanoliposome delivery, resulting
with significantlymore elastic skin and diminished wrinkles (Han
et al., 2020).
Pentapeptide-3 (Vialox)
Vialox is a pentapeptide derived from snake venom (H-Gly-
Pro-Arg-Pro-Ala-NH2) that was demonstrated to induce muscle
relaxation. It acts as an antagonist of ACh receptor, disabling the
function of nerves and preventing unwanted cramps (Schagen,
2017). Up to date, there are no further investigations directly
describing or enhancing anti-wrinkle properties of Vialox. The
only available data are provided by the manufacturer, which
reports that in vitro and in vivo studies warrant Vialox efficacy
because of wrinkle size and skin roughness decrease.
Pentapeptide-18 (Leuphasyl)
The pentapeptide-18 composed of the sequence H-Tyr-Ala-
Gly-Phe-Leu-OH, was reported for the first time in 2015. It
became one of the most popular active peptide ingredients
in anti-aging formulations (Lipotec s.a., 2005). It acts like
enkephalins, decreasing the ACh secretion in the synaptic cleft.
Both instrumental and volunteer-involving studies acknowledge
its effectiveness in wrinkles reduction (Dragomirescu et al., 2014).
It is worth to notice, that a synergistic effect of Leuphasyl and
Argireline has been proved (Lipotec s.a., 2005).
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FIGURE 1 | Relevant peptides in commercially available cosmeceuticals.
A very recent study, carried out by Park et al. and
published in 2020, concerns D-tyrosine-containing
cosmetic peptides. Their role in melanogenesis process
was clearly demonstrated (Park et al., 2020). In particular
synthetic Leuphasyl-derived peptides, obtained replacing
N-terminal L-tyrosine with D-tyrosine or adding L/D-
tyrosine at the C-terminus, were tested on human
melanoma MNT-1 cells. The decrease of melanogenesis,
particularly in the case of Leuphasyl peptide analogs
containing C-terminal D-tyrosine, was confirmed, leading
to a remarkable cosmeceutical with dual-anti-wrinkle and
whitening properties.
Tripeptide-3 (Syn-Ake)
Another relevant example of peptide, acting similarly to the
aforementioned Leuphasyl, is the Tripeptide-3 (H-β-Ala-Pro-
Dab-NH-benzyl × 2·AcOH) (e.g., Dipeptide Diaminobutyroyl
Benzylamide Diacetate), commercially known as Syn-Ake (Reddy
et al., 2012). As a reversible antagonist of muscular nicotinic
ACh receptors, Tripeptide-3 prevents ACh binding to the
receptor. Afterwards, sodium ion channels remain closed,
depolarization does not take place, and muscles cannot cramp.
The manufacturer claims in the information, in vitro and
in vivo studies about the reversible mechanism of action (0.5mM
concentration), but put also in evidence that 28-days application
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FIGURE 2 | Influence of SA1-III peptide (KP1) on collagen turnover in human dermis.
of Syn-Ake, reduced the visibility of wrinkles up to 52%
(DSM, 2020).
To the best of our knowledge, until now there are no scientific
papers describing clinical studies or modifications of Tripeptide-
3. However, different formulations containing this peptide are
available on the market: face creams, serums, and eye patches
(DSM, 2020).
Acetyl Octapeptide-1/-3 (SNAP-8)
One the latest discovery of cosmeceutical industry includes
Acetyl Glutamyl Heptapeptide-3 (Ac-Glu-Glu-Met-Gln-Arg-
Arg-Ala-Asp-NH2) and SNAP-8 (e.g., Acetyl Octapeptide-1 or-3)
(Lipotec s.a., 2020). Muscle contraction is decreased, due to
the modulated formation of SNARE complex, in which SNAP-
8 is mimicking SNAP-25 and makes it acting as a competitive
inhibitor. Consequently, glutamate release is declined and
inhibition level spans 43% in the case of 1.5mM concentration
of SNAP-8. According to the data available in the manufacturer’s
website, maximum wrinkle reduction strives for−62%, with
the mean value at the level of −35%. It is also worth to
be remarked that in vitro assay highlighted an independent
mechanism but synergistic effect between SNAP-8 and Leuphasyl,
each one tested independently and resulting with 38% and 7%
inhibition, respectively. In the trial, including both of them in
equal concentrations (0.75mM), a total inhibition value of 47%
was observed.
CARRIER PEPTIDES
Cu(II), one of the crucial metal ions in human body, can be
stabilized or delivered into cells among others, by peptides.
It is incorporated in various processes, including enzymatic
reactions, wound healing, and angiogenesis (Husein el Hadmed
and Castillo, 2016). In the case of cosmeceuticals, copper is
an essential cofactor for lysyl oxidase over the formation of
collagen or elastin. Reducing the activity of MMPs (Matrix
metalloproteases) and collagenase, prevent premature skin-aging
(Blanes-Mira et al., 2002; Lupo and Cole, 2007). The most
important peptide of this class is Gly-His-Lys.
Copper Tripeptide-1 (Cu-GHK)
H-Gly-His-Lys-OH, isolated for the first time from human
serum albumin (HSA) and proposed also as palmitoylated
derivative, was demonstrated to be able to complex Cu(II)
spontaneously, thus simplifying its absorption (Pickart
and Thaler, 1973; Pickart and Margolina, 2018). Different
scientific papers confirmed skin refining after the application
of GHK, entering also into details of its mechanism of action
(Campbell et al., 2012; Pickart et al., 2015).
Two main modifications of Cu-GHK peptide include: Pal-
GHK with a palmitoyl moiety linked at the N-terminus (as
discussed in Signal peptides section) and a biotin-complex
derivative, both designed to improve physical stability and
transdermal delivery (Arul et al., 2005; Jeong et al., 2019).
The most recent studies involving Cu(II)-tripeptide (e.g.,
Cu-GHK) refer to oligoarginine conjugation (Hur et al., 2020)
and D-amino acid modifications, as in the case of Leuphasyl
(Lipotec s.a., 2005). GHK-R4 (a peptide with four arginine
residues at the C-terminus), has been confirmed to exhibit
dual activity: MMP inhibitory effect and UVB exposure skin
protection. Considering its cell penetration properties, it can be
suggested that oligoarginine analogs are excellent candidates for
cosmeceutical formulations. On the other hand, a C-terminal
D-tyrosine in the GHK sequence provides additional whitening
properties, decreasing melanin production.
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Manganese Tripeptide-1 (Mn-GHK)
Hussain et al. investigated the influence of manganese complex
with GHK peptide (Hussain and Goldberg, 2007). Their study,
based on twice a day application for two weeks, showed that Mn-
GHK can be a potent ingredient in cosmeceutical formulations,
in comparison with Cu-GHK, acting mainly on wrinkles and
reducing skin hyperpigmentation.
SIGNAL PEPTIDES
In this class of cosmeceuticals, those peptides able to modulate
skin protein turnover are included, most of them enhancing
collagen production. In fact, their name derives from the ability
to signal or mimicking the signal occurring in the synthesis of
extracellular matrix (ECM) proteins. In this category, peptides
promoting collagen production and released by the ECM, are
called also matricins (Schagen, 2017). One of the first peptide
used with a similar activity is the gastrin-releasing peptide, a
bombesin-like neuropeptide that promotes wound healing by
stimulating keratinocyte proliferation (Yamaguchi et al., 2002).
We will report several other recently discovered signal peptides,







is an analog of the peptide sequence H-Val-
Gly-Val-Ala-Pro-Gly-OH, a hexapeptide that was discovered
working on elastin derived peptides (Senior et al., 1984). In
fact, this peptide sequence is repeated several times in human
and other animal elastins. It stimulates collagen production
and decreases the synthesis of elastin, with chemotactic activity
and metalloproteinases upregulation properties (Floquet et al.,
2004). The addition of the palmitoyl moiety at the N-terminus
confers enhanced permeation ability, and the resulting peptide
is used in a wide range of cosmeceuticals. Sederma, a group
from Croda International company, proposes Biopeptide EL
TM
that is a mixture of Palmitoyl hexapeptide-12 with glyceryl
polymethacrylate and PEG-8. The mixture is claimed for anti-
aging properties thanks to its ability to stimulate fibroblasts
mobility (Croda International Plc, 2020a).
Palmitoyl Pentapetide-4 (Matrixyl®)
Matrixyl R© is the new version of Pentapeptide-4 (palmitoylated
Lys-Thr-Thr-Lys-Ser-OH), the well-known signal peptide
fragment of the C-terminal propeptide of type I collagen. It
stimulates feedback regulation of new collagen synthesis and
ECM proteins. The conjugation with the palmitoyl moiety results
in more effective delivery across the skin and better stability to
skin proteases (Choi et al., 2014).
In vivo studies on 93 women, including placebo subjects,
and conducted in a double-blind clinical study, show that an
application of that palmitoylated peptide improves reduction of
fine lines and wrinkles (Robinson et al., 2005). An advanced study
on new analogs of Pentapetide-3 was recently published (Tałałaj
et al., 2019).
Palmitoyl Tripeptide-1 (Biopeptide CL
TM
)
As above described, Tripeptide-1 (H-Gly-His-Lys-OH) is a
carrier when in complex with Cu(II). In reverse, the peptide
itself is a signal peptide able to enhance collagen production.
In vitro and in vivo studies showed an increased stimulation
of collagen and glycosaminoglycan (GAG) synthesis with a
visible reduction of wrinkles in terms of length, depth, and
roughness. Palmitoyl Tripeptide-1 is used in Biopeptide CL
TM
and in combination with Pal-GQPR in Matrixyl
TM
3000, both
developed by Sederma as an anti-aging serum, stimulating
collagen production (Cosmetic Ingredient Review, 2012; Johnson
et al., 2018; Croda International Plc, 2020b). Its activity is
comparable to retinoids, but Biopeptide CL
TM
has the big
advantage not to induce skin irritation.
Palmitoyl Tripeptide-5 (Syn®-Coll)
Palmitoyl Tripeptide-5 is composed only of lysine and valine
residues (H-Lys-Val-Lys-OH) with a palmitoyl moiety at the
N-terminus. This patented peptide is commercialized with the
brand Syn R©-Coll by DSM. It acts stimulating TGF-β, a growth
factor, which induces collagen biosynthesis, and inhibits matrix
metalloproteases degrading collagen. The visible effects of this
mechanism of action are improved firmness and elasticity of
the skin.
It is also described that conjugation of an L-ascorbate moiety
(AA) at the C-terminus (Pal-KVK-AA) is beneficial because
it inhibits melanin synthesis in vitro, which is translated into
a depigmentation effect. In vivo data are also available in the
literature (Kim et al., 2017).
Lipospondin
Lipospondin is the elaidyl conjugate of the peptide sequence
KFK (Elaidyl-Lys-Phe-Lys-OH). The fatty acid moiety is possibly
inhibiting MMPs mRNA and the tripeptide itself stimulates
TGF-β. It is also demonstrated that the peptide upregulates
collagen and tissue MMP-1 inhibitors production (TIMP-1), and
downregulates MMP-1 in fibroblasts (Cauchard et al., 2004).
Hexapeptide-11 or Pentamide-6
This double-named peptide (H-Pro-Val-Ala-Pro-Phe-Pro-OH)
was isolated for the first time from Saccaromyces yeast
fermentation. It was reported to protect fibroblasts against
oxidative stress-mediated premature cellular senescence by
mediating a downregulation of cellular proteins, such as ataxia
telangiectasia mutated (ATM) and p53, which are hyperactive
in degenerative aging pathologies. In vivo data also showed an
improvement in skin elasticity (Sklirou et al., 2015).
Tripeptide-10 Citrulline (Decorinyl®)
Tripeptide-10 citrulline, named also T10-C, includes a citrulline
residue in the sequence of Tripeptide-10, and it is commercialized
by Lipotec as Decorinyl R©. It regulates collagen fibers diameter,
increasing the quality of the endogenous collagen, without
affecting its synthesis (Puig et al., 2008). It is structurally
related to decorin, a human protein influencing fibrillogenesis,
and interacts with several proteins or factors involved in
various physiological cascades. Due to chronologically skin aging,
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decorin concentration decreases more and more and a use of
T10-C peptide could mimic this function.
Raikou et al. also tested its activity in combination with
the well-known acetyl hexapeptide-3, demonstrating that a
formulation composed of both of them could provide synergistic
rejuvenation effects to the skin (Raikou et al., 2017).
PKEK
The tetrapeptide H-Pro-Lys-Glu-Lys-OH is used in different
formulations for skin depigmentation. In particular, this peptide
was reported to reduce pigmentation by decreasing interleukin-
6 and -8 (IL-6 and IL-8), α-melanocyte-stimulating hormone
(α-MSH), and tumor necrosis factor-α (TNF-α) expression in
in vitro and double-blind clinical studies (Marini et al., 2012).
Successful delivery of the hydrophilic and polar peptide
sequence, was achieved with nano-sized carrier systems, which
improved topical bioavailability (Neubert et al., 2018).
GEKG
The tetrapeptide H-Gly-Glu-Lys-Gly-OH is a collagen synthesis
stimulator, developed by an in silicomolecular design. It is shown
that, in comparison with placebo, this tetrapeptide significantly
decreases skin roughness, and thereby wrinkles (Farwick et al.,
2011; Sommer et al., 2018).
A recent study showed that conjugation with vitamin C by a
succinyl moiety as a linker [e.g., ascorbyl succinyl tetrapeptide
(AST)], increases expression of basement proteins resulting in a
synergistic anti-aging effect (Jeong et al., 2019).
SA1-III (KP1)
As last example, we report a peptide, recently described by
our group (Pascarella et al., 2016), which can be included
in the family of the signal peptide class, since it modulates
skin protein turnover, but apparently through a molecular
mechanism based on inhibition of collagen degradation
by proteases. In fact, SA1-III is a decapeptide (Ac-Met-
Gly-Lys-Val-Val-Asn-Pro-Thr-Gln-Lys-NH2) formally
derived from the C-terminal portion of serine protease
inhibitor A1 (Serpin-A1), a physiological inhibitor of
neutrophil elastase, a protease involved in the degradation
of ECM components.
Bioactivity of peptide SA1-III is summarized in Figure 2. In
particular SA1-III tested in cultured human dermal fibroblasts,
showed a good collagen modulation, protecting collagen against
degradation without detectable actions on biosynthesis, acting
at reasonably low concentrations, and non-interfering with cell
proliferation (Cipriani et al., 2018).
SUSTAINABLE SYNTHESIS OF BIOACTIVE
PEPTIDES
Synthesis of peptides is essentially based on two relevant
strategies: liquid-phase and solid-phase peptide synthesis (LPPQ
and SPPS, respectively). Hybrid procedures are often convenient
particularly in the case of longer sequences (Isidro-Llobet et al.,
2019). The most important drawback of these approaches
concerns environmental impact of most of the chemicals used
in the synthetic procedures. Therefore, researchers should
always be mindful in decreasing chemical pollutions generated
during the laboratory operations. Considering that most of the
cosmeceutical peptides are short sequences, their production
by recombinant strategies is not convenient. Peptide chemists
have to make an effort in developing more sustainable chemical
strategies for the production of these bioactive cosmeceuticals.
Indeed, research in this field is active as shown in recent
papers, particularly aimed to microwave-assisted SPPS. Special
attention is paid to alternative greener coupling reagents such
as ethyl 2-cyano-2-(hydroxyimino)acetate, named also oxyma,
replacing the commonly used HOBt and HOAt benzotriazole-
based activators (Subirós-Funosas et al., 2009). Substitution
of the hazardous solvent N,N-Dimethylformamide (DMF) by
the biomass-derived γ-valerolactone was recently reported to
achieve yields comparable to standard methodologies and
proposed as the greenest approach, in terms of the solvent
used, waste generated and energy efficiency (Kumar et al.,
2018).
CONCLUSIONS
In this mini-review we inquired the mostly used cosmeceutical
peptides in the last decade. Noteworthy, cosmeceutical peptides
are mainly characterized by short sequences as depicted in
Figure 1. This represent a remarkable advantage in terms of
production cost and scale-up.
The analysis of the recent literature on bioactive peptides as
ingredients of cosmeceutical products shows that an increasing
number of scientific studies support the claimed biological
activity of these peptides, thus rationally underpinning the
growth of this field in the framework of a sustainable
wellness economy.
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